オンデマンド配信 on-demand...

On-demand distributing
IL1 Post-Traumatic Headache Professor of Neurology, President of the International Headache Society, Danish Headache Center & Department of Neurology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark Messoud Ashina, M.D., Ph.D, DMSc, FEAN
2 InvitedLecture2

IL2 Neuroimaging of Headache Chairman, National Yang-Ming University School of Medicine, Faculty of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan Shuu-Jiun Wang, M.D., Ph.D
4SponsoredSeminar4
Analyzing headache diary from the perspective of the prevention of chronic migraine
The risk factors for migraine progression and chronification in Psychosomatic Medicine
Closing

5SponsoredSeminar5

SS5 The role of Kampo treatment in Headache

SS6 Epilepsy and headache

-COVID Topics-COVID
Maintaining Quality Telemedicine for Chronic Headache Management during the COVID-19 Pandemic
T-2 COVID-19 Status and factors of withholding headache outpatient clinic due to the COVID-19 pandemic 1 2
1 2
8

T-3 COVID19 Headache in COVID19-positive patients
T-4 COVID-19 Online headache treatment under COVID-19 Based on our experience
T-5 COVID-19 Clinical characteristics of headache in patients with COVID-19
T-6 COVID-19 COVID-19 patient with headache
1OralPresentation1
Clinical features of eight migraine patients who revealed morning headache 1 2 3 4 5
1 1 1 2 3 4 2 1 1,5
O1-2 Attention and executive functions of migraine patients 12 3 4 5
123 4 5
O1-3 cortical spreading depression Association between changes in body temperature and cortical spreading depression
O1-4 The relationship between cranial autonomic symptoms and central sensitization in migraine patients 1 2 3
1 1 11Johanna Wolf2 2 31
9

O1-5 Relationship between central sensitization and restless legs syndrome in patients with migraine 1 2
1 1 2 1 1 2 1
O1-6 Photosensibility of migraine patient 1 2
11 1 2
2OralPresentation2
O2-1
1 A case of migraine without aura with reduced headache frequency after mitral valve plasty for mitral regurgitation
O2-2 Evans 1 A Case of Evans Syndrome Mimicking Retinal Migraine 1 2 3 4 5
1 1 1 2 3 4 4,5 1 1
O2-3 2 Two cases of Visual snow
3 OralPresentation3
O3-1 lasmiditan 2 MONONOFU
Phase 2 study of lasmiditan for a single migraine attack in Japanese patients with migraine MONONOFU 1 2 3
12 3 3 3 3
10

4 OralPresentation4
Effectiveness of low-dose flavin adenine dinucleotide sodium in migraine prophylaxis
O4-2 Preventive effect of Lomerizine Hydrocloride on different age groups 1 2 3 4 5
1 23 4 5
O4-3 The characteristic of long-term lomerizine administration
O4-4 Application of psychological theory in migraine treatment
5 OralPresentation5
Efficacy and safety of subcutaneous administration of Fremanezumab for patients with episodic migraine.Phase 2b/3 study 1 2 34 Nowon Eulji Medical Center, Eulji University5
1 2 3 4Byung Kun Kim5 1
O5-2 fremanezumab Efficacy and safety of subcutaneous administration of Fremanezumab for patients with chronic migraine. Phase 2b/3 study 1 2 3 4 Nowon Eulji Medical Center, Eulji University5
1 2 3 4Byung Kun Kim5
11

O5-3 Phase 3 study on long-term safety and tolerability of subcutaneous administration of Fremanezumab for the preventive treatment of migraine 1 2 34 5
1 2 3 45 1
O5-4 Efficacy and Safety of Fremanezumab Versus Placebo for the Preventive Treatment of Episodic Migraine EM and Chronic Migraine CM in a Subpopulation of Japanese Patients: Results from the Randomized, Double-blind, Phase 3 HALO Studies Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA1, Teva Pharmaceuticals K.K., Tokyo, Japan2, Saitama International Headache Center, Saitama, Japan3
Xiaoping Ning1, Joshua Cohen1, Mary Wu1, Toshio Nagaoka2, Fumihiko Sakai3
6 OralPresentation6
CGRP erenumab O6-1 Sustained efficacy and long-term safety of erenumab in patients with episodic
migraine: results of a 5-year, open-label extension study Dept Neurology, Danish Headache Center, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark1, NIHR-Wellcome Trust King’s Clinical Research Facility, King’s College London, UK2, Dept Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany3, Jefferson Headache Center, Thomas Jefferson University, Philadelphia, PA4, Dept of Neurology, Mayo Clinic, Scottsdale, AZ5, Amgen Inc., Thousand Oaks, CA6
Messoud Ashina1, Peter J Goadsby2, Uwe Reuter3, Stephen Silberstein4, David W Dodick5, Fei Xue6, Feng Zhang6, Sunfa Cheng6, Denise E. Chou6, Gabriel Paiva da Silva Lima6
O6-2 Erenumab treatment for migraine prevention in Japanese patients: primary results of a phase 3, randomized, double-blind, placebo-controlled study Global Development, Amgen Inc., Thousand Oaks, CA, USA1, Headache Center, Department of Neurology, Tominaga Hospital, Osaka, Japan2, Saitama International Headache Center, Saitama, Japan3, Department of Neurology, Dokkyo Medical University, Tochigi, Japan4, Department of Neurology, Japanese Red Cross Shizuoka Hospital, Shizuoka, Japan5, Sendai Headache and Neurology Clinic, Sendai, Japan6, Amgen K.K., Tokyo, Japan7, Global Biostatistical Science, Amgen Inc., Thousand Oaks, CA, USA8
Sunfa Cheng1, Takao Takeshima2, Fumihiko Sakai3, Koichi Hirata4, Noboru Imai5, Yasuhiko Matsumori6, Ryuji Yoshida7, Cheng Peng8, Daniel D. Mikol1
12

O6-3 Efficacy of erenumab in Japanese patients with migraine treated with concomitant preventives compared to no concomitant preventives: subgroup analysis of a phase 3 study, randomized, double-blind, placebo-controlled study Global Development, Amgen Inc., Thousand Oaks, CA, USA1, Department of Neurology, Japanese Red Cross Shizuoka Hospital, Shizuoka, Japan2, Headache Center, Department of Neurology, Tominaga Hospital, Osaka, Japan3, Saitama International Headache Center, Saitama, Japan4, Department of Neurology, Dokkyo Medical University, Tochigi, Japan5, Sendai Headache and Neurology Clinic, Sendai, Japan6, Amgen K.K., Tokyo, Japan7, Global Biostatistical Science, Amgen Inc., Thousand Oaks, CA, USA8
Sunfa Cheng1 , Noboru Imai2, Takao Takeshima3, Fumihiko Sakai4, Koichi Hirata5, Yasuhiko Matsumori6, Yotaro Numachi7, Cheng Peng8, Daniel D. Mikol1
O6-4 Efficacy of erenumab in Japanese patients with migraine with prior preventive treatment failure compared to non-failure: subgroup analysis of a phase 3 study, randomized, double-blind, placebo-controlled study Global Development, Amgen Inc., Thousand Oaks, CA, USA1, Sendai Headache and Neurology Clinic, Sendai, Japan2, Headache Center, Department of Neurology, Tominaga Hospital, Osaka, Japan 3, Saitama International Headache Center, Saitama, Japan4, Department of Neurology, Dokkyo Medical University, Tochigi, Japan5, Department of Neurology, Japanese Red Cross Shizuoka Hospital, Shizuoka, Japan6, Amgen K.K., Tokyo, Japan7, Global Biostatistical Science, Amgen Inc., Thousand Oaks, CA, USA8
Sunfa Cheng1, Yasuhiko Matsumori2, Takao Takeshima3, Fumihiko Sakai4, Koichi Hirata5, Noboru Imai6, Yotaro Numachi7, Cheng Peng8, Daniel D. Mikol1
7OralPresentation7
Treatment satisfaction of galcanezumab in Japanese patients with episodic migraine 1 23
12 3 3
O7-2 galcanezumab 3 Phase 3 Study of Galcanezumab in Patients with Treatment-Resistant Migraine 12Eli Lilly and Company3
1 2 2Holland C. Detke3
13

O7-3 galcanezumab CGAP Long-Term, Open-Label Safety Study of Galcanezumab in Japanese Patients with Migraine CGAP study 1 2 3 4 56 7Eli Lilly and Company8
1 2 3 4 5 6 7 7 7Vladimir Skljarevski8
8OralPresentation8
O8-1 OTC
Analgesic actions of OTC antipyretic drugs in a mouse model of tension-type headache
9OralPresentation9
TAC O9-1
Clinical features of cluster headache patients in Keio University Hospital Headache Clinic 1 2 1 1,2 1 1 1
O9-2 3 -3rd Report-The New Prophylactic Treatment for Episodic Cluster Headache by Administration of Live Attenuated Zoster Vaccine
O9-3 Cluster-tic syndrome 1 A case report of suspected cluster-tic syndrome 1 23 1 2 1 1 1 1 3 1 3 1
14

10OralPresentation10
O10-1 Japan OVERCOME study
Cross-sectional population-based web survey for people with migraine in Japan - Results of Japan OVERCOME study 12 Eli Lilly and Company3Kantar Health45 6
1 2 2Anthony J. Zagar3Dena H. Jaffe4 5 6
O10-2 2019 1 12 The poor physical condition at the time of the weather change and statistics about a headache for 2019 years
O10-3 HIT-6 Changes in headache days and HIT-6 scores in primary headache patients 1 2
1 1 1 1,2
O10-4 Headache caused by smartphone
O10-5 Study of the conditions about patients with chronic headche in our obstetrics and gynecology clinic
O11-1 MOH
Clinical Analysis of Medication - Overuse Headache MOH
O12-1 1
A case of vertebrobasilar dissection with headache onset
15

O12-2 1 A case of headache caused by spontaneous dissection of the cervical internal carotid artery
O12-3 Clinical study of vertebral artery dissection with headache in our clinic 12 1 2
O12-4 Walk in SAH Experience of subarachnoid hemorrhage in headache outpatient. Analysis of so-called Walk in SAH
O12-5 2 Two cases of cerebral venous thrombosis with headache
O12-6 1 A case of Diploic arteriovenous fistula presenting in a short period 1 2 1 1 1,2 11
Reversible cerebral vasoconstriction syndrome triggered by typhoon Hagibis in 2019: report of 2 cases 1 2
1 1 1 1,2 1
O13-2 RCVSASL-MRI Comparison of arterial spin-labeling ASL MRI findings in RCVS with migraine during a headache attack
O13-3 7 1 A case of the reversible cerebral vasoconstriction syndrome in 7-year-old boy 12 1 2 2
16

Classification of headaches associated with Rathke's cleft cyst according to their onsets 1 2 1 2 2 1 2 1
O14-2 A case of pregnancy with headache induced lymphocytic pituititis
O14-3 Clinical and imaging features of pituitary apoplexy diagnosed at headache clinic
O14-4 Efficacy of cabergoline and triptans for cluster-like headache caused by prolactin- secreting pituitary adenoma: a case report
A case of idiopathic intracranial hypotension accompanied with spinal presyrinx formation
O15-2 A case of Cerebrospinal Fluid Leak with superficial siderosis 1 2 3
1 1 12 3 1
O15-3 CH Various aspects of CSF hypovolemia CH
17

O15-4 Efficacy of Continuous Epidural Saline infusion in Spontaneous Cerebrospinal hypovolemia
O15-5 Jidabokuippou might be effective to the neck pain of CSF hypovolemia
O15-6 The problems considered through medical treatment of cerebrospinal fluid leakage syndrome caused by a traffic accident from the viewpoint of a neurologist
O16-1 HIT-6 ESS
Evaluation of sleep apnoea headache based on HIT Headache Impact Test - 6 and ESS Epworth Sleepiness Scale
O17-1
A case of suspected neurosweet disease with prolonged meningitis
O17-2 - A case of Varicella Zoster Virus Meningitis with migraine-like symptoms
O17-3 MRI 1 A case of normal MRI pachymeningitis presenting left frontal headache and focal epilepsy 1 2
1 2
O17-4 A case of Neuromyelitis optica spectrum disorder whose chief complaint was headache 1 2
1 1 1 2 1 1
18

A case report; Adolescent women with POTS visiting headache outpatient department
O18-2 3 Three cases of severe headache with sphenoid sinusitis
O18-3 The incidence of motion sickness in childhood migraine patients and its management
O19-1
The headaches after general anesthesia in GYN. surgeries 1 2 12
A case of difficult diagnosis of atlantoaxial osteoarthritis with greater occipital neuralgia
O20-2 unilateral alar ligament injury 1 A case of unilateral alar ligament injury as sudden onset neck pain
O20-3 1 A case of cervicogenic headache worsend by dropped head syndrome of Myasthenia gravis 1 2 1 1 1 1 1 1 2
19

O20-4 A Case of Cervical Pain and Headache due to Intramedullary Cervical Spinal Cord Abscess in adult
Headache attributed to Idiopathic intracranial hypertension: case report
O21-2 Case of headache after cataract surgery
O21-3 A case of external compression headache associated with wearing a helmet
O22-1 1
A case of dialysis headache for which Kampo treatment was effective:A case report
O22-2 Effective Kampo therapy for dizziness of migraine
O22-3 1 A case of auditary nerve tumor which Goreisan was effective for headache
O22-4 A case where combined use of Kamishoyosan was effective for exacerbation of migraine due to stress
20

O22-5 A Survey of Hospitalized Headache Patients Requested for Acupuncture Second Report 1 2 1 1 1 2 2
Headache as biomarker of Chronic subdural hematoma outcome 1 2 1 11 2
O24-1
The crosstalk between migraine and epilepsy
O25-1
Trigeminal neuralgia only by vein compression
O25-2 SUNA A case of idiopathic trigeminal neuralgia with concomitant continuous pain that was difficult to differentiate from SUNA 1 2 3 1 2 3
O25-3 A successful case of bilateral trigeminal neuralgia with microvascular decompression
O25-4 1 Glossopharyngeal neuralgia where microvascular decompression was successful. A case report 1 2 1 1 1 1 2
21

O26-1
Undergraduate headache education in Japan: National survey
O26-2 Residents' attitude toward headache patients; Findings from Questionnaire 1 2 1 1,2 1,2 1 1,2
O27-1 OSIT-J
Analysis of the relationship between migraine and smell using OSIT-J 1 2 1 1 1 1 2 2 1,2 1,2
O27-2 HM ATP1A2 Analysis of causative ATP1A2 gene in hemiplegic migraine HM 1 2 3 4
1 3 1,2 3 4 2 2 23 2
O27-3 The frequency and characteristics of cold stimulus headaches 1 2 1 1 1 1 1 12 2 1,2
O27-4 Multidisciplinary treatment for chronic headache from the viewpoint of clinical psychologist 1 2 1 1 1 1 2 1
O27-5 MRI How to devise a way to take MRI image on cough headache
O27-6 The efficiency of proxy input electronic medical records by clerk
22

O27-7 Verification of cases who became restless during infusion therapy for migraine attacks
23

オンデマンド配信 on-demand...

Documents